Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Describing the Quality Of Life in Colombian Patients mCRPC Under Treatment With RADium-223.

NCT04681144 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04681144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04681144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Describing the Quality Of Life in Colombian Patients mCRPC Under Treatment With RADium-223.
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
April 8, 2021
Completion date
November 21, 2022
Enrollment
103 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer